ARTICLE | Company News
BioGenes GmbH, Cellmid sales and marketing update
November 22, 2010 8:00 AM UTC
Cellmid launched BioGenes' MK ELISA globally for research use to measure midkine ( MDK; MK) in blood serum. The company said MDK has been found to correlate with cancer progression and malignancy. ...